Skip to main content
. 2020 Jul 30;11:3819. doi: 10.1038/s41467-020-17644-0

Fig. 2. M/D-driven oncogenesis is under immunosurveillance by NK cells.

Fig. 2

a, b Tumor-free survival (TFS), overall survival (OS) and time-to-death (TTD) of WT C57BL/6 mice (a, b) and Rag2/Il2rg/ mice (a) or Ifng/ mice (b) subjected to M/D-driven oncogenesis. Number of mice, hazard ratio (HR) and p values (two-sided log-rank) are reported. ce. Variations in TFS (c), OS (d) and TTD (e) imposed to M/D-driven oncogenesis in mice by the indicated genotype or immunomodulatory interventions. Results are means ± SEM plus individual data points. Number of mice, HR and p values (two-sided log-rank and one way-ANOVA plus Fisher LSD, calculated with respect to individual control experiments) are reported. Green dots indicate mice that were free of disease (c) and alive (d) at the end of the experiment. fh TFS and OS of WT C57BL/6 (fh) mice and Rag2/ BALB/c mice (f), C57BL/6 mice receiving NKG2D-depleting antibodies (g), or C57BL/6 mice receiving CD4- and CD8-depleting antibodies (h). Number of mice, HR and p values (two-sided log-rank) are reported.